IL88293A0 - Alveolar surfactant proteins - Google Patents

Alveolar surfactant proteins

Info

Publication number
IL88293A0
IL88293A0 IL88293A IL8829388A IL88293A0 IL 88293 A0 IL88293 A0 IL 88293A0 IL 88293 A IL88293 A IL 88293A IL 8829388 A IL8829388 A IL 8829388A IL 88293 A0 IL88293 A0 IL 88293A0
Authority
IL
Israel
Prior art keywords
alveolar surfactant
surfactant proteins
alveolar
human
peptides
Prior art date
Application number
IL88293A
Other languages
English (en)
Original Assignee
California Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Biotechnology Inc filed Critical California Biotechnology Inc
Publication of IL88293A0 publication Critical patent/IL88293A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
IL88293A 1987-11-04 1988-11-04 Alveolar surfactant proteins IL88293A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11709987A 1987-11-04 1987-11-04
US26644388A 1988-11-01 1988-11-01

Publications (1)

Publication Number Publication Date
IL88293A0 true IL88293A0 (en) 1989-06-30

Family

ID=26814915

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88293A IL88293A0 (en) 1987-11-04 1988-11-04 Alveolar surfactant proteins

Country Status (9)

Country Link
EP (1) EP0383837B1 (da)
JP (1) JP2602968B2 (da)
KR (2) KR960010558B1 (da)
AT (1) ATE163013T1 (da)
AU (1) AU625394B2 (da)
CA (1) CA1340461C (da)
DK (1) DK175843B1 (da)
IL (1) IL88293A0 (da)
WO (1) WO1989004326A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104853A (en) * 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
JPH04501204A (ja) * 1988-08-11 1992-03-05 サイオス　ノバ　インコーポレイテッド 異種タンパク発現を安定させる方法およびそれに使用するベクター
CA2063273C (en) * 1989-07-11 2002-09-24 Bradley J. Benson Surfactant compositions and methods
US5258496A (en) * 1990-07-10 1993-11-02 Scios Nova Inc. Isolation and purification of lung surfactant protein
US5272252A (en) * 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties
ES2189825T3 (es) * 1993-12-08 2003-07-16 Mitsubishi Pharma Corp Nuevo peptido sintetico, tensioactivo pulmonar que lo contiene y remedio para el sindrome de malestar respiratorio.
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
WO2000005585A1 (en) 1998-07-24 2000-02-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Determination of the hydrophobic pulmonary surfactant protein sp-c
AU5074400A (en) 1999-06-17 2001-01-09 Byk Gulden Lomberg Chemische Fabrik Gmbh Surfactant protein c esters
WO2001019392A1 (en) 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
ES2346048T3 (es) 2001-10-11 2010-10-08 Nycomed Gmbh Nueva utilizacion de un agente tensioactivo pulmonar.
AU2002357168A1 (en) 2001-12-12 2003-07-09 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
CA2575513C (en) 2004-08-06 2014-09-16 Altana Pharma Ag Composition comprising a pulmonary surfactant and a tnf-derived peptide
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
JP2008526868A (ja) 2005-01-06 2008-07-24 ディスカバリー ラボラトリーズ，インコーポレイテッド 表面活性剤処置療法
KR20090060348A (ko) 2006-09-19 2009-06-11 디스커버리 래보래토리스, 인크. 폐 계면활성제 제제 및 점액 클리어런스 촉진 방법
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
JP5506792B2 (ja) 2008-06-25 2014-05-28 ブラーシュ・バイオテック・エルエルシー クロラムフェニコールアセチルトランスフェラーゼ（ｃａｔ）不完全ソマトスタチン融合タンパク質およびその使用
EP2291194B1 (en) 2008-06-25 2017-02-22 Braasch Biotech LLC Compositions and methods for enhanced somatostatin immunogenicity
AU2009324637B2 (en) 2008-12-10 2016-09-08 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation
WO2016029013A2 (en) 2014-08-21 2016-02-25 Braasch Biotech Llc Methods for improving immunological response in vaccinated animals
DE102016125491A1 (de) 2016-12-22 2018-06-28 Bombardier Transportation Gmbh Zugverband mit mindestens einer Aufhängungsvorrichtung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
WO1988003170A1 (en) * 1986-10-24 1988-05-05 Whitsett Jeffrey A Pulmonary hydrophobic surfactant-associated proteins

Also Published As

Publication number Publication date
EP0383837A4 (en) 1991-09-11
CA1340461C (en) 1999-03-23
AU2797989A (en) 1989-06-01
JP2602968B2 (ja) 1997-04-23
ATE163013T1 (de) 1998-02-15
KR960010558B1 (ko) 1996-08-02
WO1989004326A1 (en) 1989-05-18
JPH03502095A (ja) 1991-05-16
DK110190A (da) 1990-07-04
EP0383837A1 (en) 1990-08-29
AU625394B2 (en) 1992-07-09
KR900700505A (ko) 1990-08-13
DK110190D0 (da) 1990-05-03
DK175843B1 (da) 2005-03-29
EP0383837B1 (en) 1998-02-04

Similar Documents

Publication Publication Date Title
DK110190A (da) Alveolaere surfaktantproteiner
AU573523B2 (en) Functional human urokinase proteins
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
FI884051L (fi) Menetelmä stabiloitujen humaaniproteiinivalmisteiden valmistamiseksi
ATE140963T1 (de) Verfahren zur herstellung von sekretierten rezeptoranalogen
GB2181138B (en) Recombinant alveolar surfactant protein
ATE122357T1 (de) Polypeptide mit hormonwachstumsbefreiender wirkung.
IL99401A0 (en) Nucleotide sequence coding for an outer membrane protein and use of said protein in vaccine preparations
CA2083177A1 (en) Alveolar surfactant proteins
AU1723888A (en) Whey protein fractions
PT87688A (pt) Hybrid protein c and method for its preparation
EP0483247A4 (en) Recombinantly produced human membrane cofactor protein (mcp)
IL91234A0 (en) Hybrid protein c constructs and methods for their preparation
ES2072490T3 (es) Procedimiento para la pasteurizacion de la proteina tisular pp4.
FI893545A7 (fi) Ihmisen proteiini C:n mutantteja ja menetelmä niiden valmistamiseksi
AU1996388A (en) Proteins and protein compositions and their use
NO891926L (no) Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater.
PT86162A (en) Recombinant protein expression
ZA901695B (en) Recombinant protein receptor
AU1294888A (en) Recombinant alveolar surfactant protein
SE8702724D0 (sv) Proteins and protein compositions and their use
IE893442L (en) Recombinant dna sequence capable of expressing bovine¹trophablast protein
LV10393A (lv) Savietojams cilveka olbaltumvielas preparats
IE873131L (en) Recombinant protein expression.
IE871109L (en) Recombinant alveolar surfactant protein